Published in Biochem J on August 01, 1989
Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging (Albany NY) (2011) 1.09
Regulation of glycogen synthase activation in isolated hepatocytes. Mol Cell Biochem (1996) 0.82
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
The effects of glucose and of potassium ions on the interconversion of the two forms of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparations. Biochem J (1975) 2.72
Radioactive method for the assay of glycogen phosphorylases. Anal Biochem (1972) 2.51
Glycogen synthase: a new activity ratio assay expressing a high sensitivity to the phosphorylation state. FEBS Lett (1979) 1.69
Rapid stimulation by vasopressin, oxytocin and angiotensin II of glycogen degradation in hepatocyte suspensions. Biochem J (1978) 1.40
The influence of vasopressin and related peptides on glycogen phosphorylase activity and phosphatidylinositol metabolism in hepatocytes. Biochem J (1979) 1.33
Insulin control of rat hepatocyte glycogen synthase and phosphorylase in the absence of glucose. FEBS Lett (1977) 1.15
Effect of hormones on content of purine nucleoside cyclic monophosphates in perfused rat liver. FEBS Lett (1978) 0.98
Glycogenolytic, noninsulin-like effects of vanadate on rat hepatocyte glycogen synthase and phosphorylase. J Biol Chem (1987) 0.95
Insulin and oxytocin effects on phosphoinositide metabolism in adipocytes. J Biol Chem (1988) 0.89
A dual mechanism of action of ocytocin in rat epididymal fat cells. J Biol Chem (1981) 0.89
Hormonal effects on the phosphorylation of glycogen synthase in rat hepatocytes. FEBS Lett (1984) 0.89
Characterization of oxytocin receptors on isolated rat fat cells. Eur J Biochem (1975) 0.87
Actions of vasopressin-related peptides on glycogen metabolism in the perfused rat liver. Biochem Pharmacol (1976) 0.86
Control of glycogen synthase phosphorylation in isolated rat hepatocytes by epinephrine, vasopressin and glucagon. Eur J Biochem (1984) 0.84
Phosphorylation and inactivation of rat hepatocyte glycogen synthase by phorbol esters and mezerein. Biochem Biophys Res Commun (1986) 0.83
Glucagon-stimulated phosphorylation of rat liver glycogen synthase in isolated hepatocytes. J Biol Chem (1985) 0.82
Oxytocin: anti-insulin-like effects in isolated fat cells. Arch Biochem Biophys (1984) 0.81
Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science (1999) 6.37
Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol (1994) 4.65
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood (2001) 2.73
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther (2009) 2.54
Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol (1994) 2.20
Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol (1998) 1.81
Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med (1998) 1.79
Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1994) 1.71
Glycogen synthase: a new activity ratio assay expressing a high sensitivity to the phosphorylation state. FEBS Lett (1979) 1.69
Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood (1999) 1.66
Survival after progression in patients with follicular lymphoma: analysis of prognostic factors. Ann Oncol (2002) 1.61
Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J Clin Invest (2000) 1.51
DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am J Physiol Endocrinol Metab (2001) 1.48
Bone marrow assessment in B-cell chronic lymphocytic leukaemia: aspirate or biopsy? A comparative study in 258 patients. Br J Haematol (1996) 1.44
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia (2012) 1.41
[International diffusion of clinical trials carried out in Spain. An analysis based on their publication in scientific journals]. Med Clin (Barc) (1994) 1.39
[An analysis of Spanish biomedical journals by the impact factor]. Med Clin (Barc) (1992) 1.39
Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: a report of 12 patients from a single institution. Ann Oncol (1998) 1.37
Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J (1996) 1.36
PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res (1994) 1.34
Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance. Diabetologia (2003) 1.30
Correction of diabetic alterations by glucokinase. Proc Natl Acad Sci U S A (1996) 1.30
The role of glucose 6-phosphate in the control of glycogen synthase. FASEB J (1997) 1.26
Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia (2008) 1.25
Central nervous system involvement in mantle cell lymphoma. Ann Oncol (2007) 1.22
The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte. J Biol Chem (2000) 1.20
The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma. Ann Oncol (2006) 1.18
Glucose has to be phosphorylated to activate glycogen synthase, but not to inactivate glycogen phosphorylase in hepatocytes. FEBS Lett (1992) 1.18
Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis. J Biol Chem (1996) 1.17
Cloning of a gene involved in rRNA precursor processing and 23S rRNA cleavage in Rhodobacter capsulatus. J Bacteriol (1994) 1.16
p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood (1996) 1.16
Insulin control of rat hepatocyte glycogen synthase and phosphorylase in the absence of glucose. FEBS Lett (1977) 1.15
Epidermal growth factor mimics insulin effects in rat hepatocytes. Biochem J (1986) 1.14
Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid vs. glucose oxidation. FASEB J (2001) 1.13
Residual splenic function after laparoscopic splenectomy: a clinical concern. Arch Surg (1998) 1.12
Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer (2000) 1.12
Chronic lymphocytic leukemia: a changing natural history? Leukemia (1997) 1.10
Determination of glucose-6-phosphatase activity using the glucose dehydrogenase-coupled reaction. Anal Biochem (1988) 1.09
Evidence from transgenic mice that myc regulates hepatic glycolysis. FASEB J (1995) 1.08
An epidemiological comparison of pain complaints in the general population of Catalonia (Spain). Pain (1999) 1.08
The epileptogenic effect of tranexamic acid. J Neurol (1999) 1.07
CNS involvement in mantle-cell lymphoma. J Clin Oncol (1996) 1.05
Effects of lithium ions on glycogen synthase and phosphorylase in rat hepatocytes. J Biol Chem (1986) 1.05
Glucose 6-phosphate plays a central role in the activation of glycogen synthase by glucose in hepatocytes. Biochem Biophys Res Commun (1986) 1.05
Hepatic glycogen synthesis is highly sensitive to phosphorylase activity: evidence from metabolic control analysis. J Biol Chem (2001) 1.04
Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum Gene Ther (1994) 1.04
Pyoderma gangrenosum triggered by alpha2b-interferon in a patient with chronic granulocytic leukemia. Leuk Lymphoma (1998) 1.02
Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism. Diabetologia (2013) 1.01
Identification of two essential glutamic acid residues in glycogen synthase. J Biol Chem (2000) 1.01
Glucose 6-phosphate produced by glucokinase, but not hexokinase I, promotes the activation of hepatic glycogen synthase. J Biol Chem (1996) 1.01
Mucosal mantle cell (centrocytic) lymphomas. Histopathology (1995) 1.00
In vivo genetic engineering of murine pancreatic beta cells mediated by single-stranded adeno-associated viral vectors of serotypes 6, 8 and 9. Diabetologia (2011) 1.00
Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in hepatocytes. J Biol Chem (1997) 1.00
Activation of rat adipocyte glycogen synthase by insulins. J Biol Chem (1977) 1.00
Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase. J Biol Chem (1990) 0.98
Glucose induces the translocation of glycogen synthase to the cell cortex in rat hepatocytes. Biochem J (1997) 0.98
Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase. FEBS Lett (1999) 0.98
Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Am J Pathol (1996) 0.98
Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes. J Biol Chem (1994) 0.97
Overexpression of protein targeting to glycogen in cultured human muscle cells stimulates glycogen synthesis independent of glycogen and glucose 6-phosphate levels. J Biol Chem (2000) 0.97
Chronically increased glucose uptake by adipose tissue leads to lactate production and improved insulin sensitivity rather than obesity in the mouse. Diabetologia (2010) 0.97
Overexpression of muscle glycogen phosphorylase in cultured human muscle fibers causes increased glucose consumption and nonoxidative disposal. J Biol Chem (1996) 0.96
c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas. Leukemia (1999) 0.96
Glucose induces the translocation and the aggregation of glycogen synthase in rat hepatocytes. Biochem J (1992) 0.96
The inactivation of glycogen phosphorylase is not a prerequisite for the activation of liver glycogen synthase. FEBS Lett (1979) 0.96
Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity. Am J Physiol Endocrinol Metab (2011) 0.95
Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/bovine growth hormone gene. FASEB J (1993) 0.95
Glycogenolytic, noninsulin-like effects of vanadate on rat hepatocyte glycogen synthase and phosphorylase. J Biol Chem (1987) 0.95
IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice. Diabetologia (2008) 0.95
Role of glucose 6-phosphate in the translocation of glycogen synthase in rat hepatocytes. Biochem J (1992) 0.95
Insulin-like actions of tungstate in diabetic rats. Normalization of hepatic glucose metabolism. J Biol Chem (1994) 0.95
Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas. Cancer (1994) 0.94
Overexpression of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in transgenic mice causes hepatic hyperketogenesis. J Biol Chem (1994) 0.93
Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive features. J Clin Oncol (1999) 0.93
Acceptability of visual analogue scales in the clinical setting: a comparison with verbal rating scales in postoperative pain. Methods Find Exp Clin Pharmacol (1989) 0.93
Transgenic mice overexpressing human G972R IRS-1 show impaired insulin action and insulin secretion. J Cell Mol Med (2008) 0.92
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age. Diabetologia (2010) 0.92
Differential metabolic effects of adenovirus-mediated glucokinase and hexokinase I overexpression in rat primary hepatocytes. J Biol Chem (1996) 0.92
Glycogen synthase activation by sugars in isolated hepatocytes. Arch Biochem Biophys (1988) 0.92
Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations. FASEB J (1994) 0.91
Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia. Diabetologia (1997) 0.91
Transgenic mice overexpressing alpha2A-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia (2000) 0.91
Muscle glycogen synthase translocates from the cell nucleus to the cystosol in response to glucose. FEBS Lett (1997) 0.91
Anti-inflammatory action of type I interferons deduced from mice expressing interferon beta. Gene Ther (2000) 0.91
Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression. Ann Oncol (2004) 0.91
Effects of glucose on the activation and translocation of glycogen synthase in diabetic rat hepatocytes. Eur J Biochem (1994) 0.90
Hormonal effects on the phosphorylation of glycogen synthase in rat hepatocytes. FEBS Lett (1984) 0.89
Role of AMP on the activation of glycogen synthase and phosphorylase by adenosine, fructose, and glutamine in rat hepatocytes. J Biol Chem (1990) 0.89
Purification and characterization of two cyclic AMP-independent casein/glycogen synthase kinases from rat liver cytosol. Biochim Biophys Acta (1981) 0.89